Showing 1 - 13 results of 13 for search 'Yunpeng Yang', query time: 0.02s
Refine Results
-
1
Signaling Effects in AI Streamers: Optimal Separation Strategy Under Different Market Conditions by Ying Yu, Yunpeng Yang
Published 2024-11-01Get full text
Article -
2
-
3
Mechanism and Characteristics of CH4/CO2/H2O Adsorption in Lignite Molecules by Zhihui Wen, Yunpeng Yang, Qi Wang, Banghua Yao
Published 2021-01-01Get full text
Article -
4
-
5
Metabolic engineering of Lactobacilli spp. for disease treatment by Yunpeng Yang, Peijun Yu, Yufei Huang, Wanying Zhang, Yanhong Nie, Changshan Gao
Published 2025-03-01Get full text
Article -
6
-
7
Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors by Zihong Chen, Gang Chen, Yuxiang Ma, Hongyun Zhao, Jianhua Zhan, Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Shaodong Hong, Ting Zhou, Wenfeng Fang, Li Zhang, Yaxiong Zhang
Published 2025-07-01Get full text
Article -
8
Effects of thoracic radiotherapy timing and duration on progression‐free survival in limited‐stage small cell lung cancer by Shen Zhao, Ting Zhou, Shuxiang Ma, Yuanyuan Zhao, Jianhua Zhan, Wenfeng Fang, Yunpeng Yang, Xue Hou, Zhonghan Zhang, Gang Chen, Yaxiong Zhang, Yan Huang, Li Zhang
Published 2018-09-01Get full text
Article -
9
HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype by Yan Huang, Li Zhang, Ting Yang, Hongyun Zhao, Yunpeng Yang, Ting Zhou, Jianhua Zhan, Xue Bai, Fan Luo, Qun Chen, Wenjuan Ma, Jiaxin Cao, Lusha Liu, Chaozhuo Lin
Published 2024-06-01Get full text
Article -
10
Iparomlimab and tuvonralimab (QL1706) plus chemotherapy and bevacizumab for EGFR-mutant patients with advanced non-small cell lung cancer after failure of EGFR-tyrosine kinase inhi... by Yaxiong Zhang, Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Hongyun Zhao, Ningning Zhou, Likun Chen, Ting Zhou, Gang Chen, Shen Zhao, Huaqiang Zhou, Hui Li, Xiaoyan Kang, Li Zhang, Wenfeng Fang
Published 2025-07-01Get full text
Article -
11
Phase 1b/2 study of ADG106, a 4-1BB/CD137 agonist, in combination with toripalimab in patients with advanced solid tumors by Shaoyan Lin, Yuxiang Ma, Yongsheng Wang, Yunpeng Yang, Jinhui Xue, Yan Huang, Yuanyuan Zhao, Wenfeng Fang, Shaodong Hong, Yang Zhang, Qianwen Liu, Guizhong Liu, Xiaohong She, Jiping Zha, Songmao Zheng, Yan Li, Peter Luo, Li Zhang, Hongyun Zhao
Published 2025-05-01Get full text
Article -
12
Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations. by Wenhua Liang, Xuan Wu, Wenfeng Fang, Yuanyuan Zhao, Yunpeng Yang, Zhihuang Hu, Cong Xue, Jing Zhang, Jianwei Zhang, Yuxiang Ma, Ting Zhou, Yue Yan, Xue Hou, Tao Qin, Xiaoxiao Dinglin, Ying Tian, Peiyu Huang, Yan Huang, Hongyun Zhao, Li Zhang
Published 2014-01-01Get full text
Article -
13
HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced non–small cell lung cancer by Jianhua Zhan, Jinhui Xue, Lin Wu, Zhiye Zhang, Qiming Wang, Yuxiang Ma, Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Wenfeng Fang, Yang Zhang, Qianwen Liu, Wen Xu, Yan Yang, Zhenming Chen, Baili Song, Danni Sun, Xia Sun, Peng Gao, Hongyun Zhao, Li Zhang
Published 2025-06-01Get full text
Article